EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,142 | -27.6% | 8,866 | +56.4% | 0.00% | – |
Q2 2023 | $41,611 | +67.9% | 5,667 | +139.5% | 0.00% | – |
Q1 2023 | $24,780 | -37.2% | 2,366 | -29.5% | 0.00% | – |
Q4 2022 | $39,460 | -54.6% | 3,355 | -19.4% | 0.00% | – |
Q3 2022 | $87,000 | -72.9% | 4,165 | -59.7% | 0.00% | -100.0% |
Q2 2022 | $321,000 | -27.9% | 10,323 | -5.8% | 0.00% | 0.0% |
Q1 2022 | $445,000 | -8.2% | 10,958 | -1.5% | 0.00% | 0.0% |
Q4 2021 | $485,000 | -13.9% | 11,120 | -0.8% | 0.00% | 0.0% |
Q3 2021 | $563,000 | -50.4% | 11,210 | -37.7% | 0.00% | -50.0% |
Q2 2021 | $1,135,000 | +7.1% | 17,994 | +56.4% | 0.00% | -33.3% |
Q1 2021 | $1,060,000 | -3.2% | 11,506 | -5.8% | 0.00% | 0.0% |
Q4 2020 | $1,095,000 | -38.1% | 12,210 | -29.0% | 0.00% | -40.0% |
Q3 2020 | $1,770,000 | +19.6% | 17,187 | -7.9% | 0.01% | 0.0% |
Q2 2020 | $1,480,000 | +80.5% | 18,669 | +31.7% | 0.01% | +66.7% |
Q1 2020 | $820,000 | – | 14,174 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |